Загрузка...
Augmented interleukin (IL) -15Rα expression by CD40 activation is critical in synergistic CD8 T-cell mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice
Interleukin-15 (IL-15) has potential as an immunotherapeutic agent for cancer treatment because it is a critical factor for the proliferation and activation of natural killer (NK) and CD8(+) T cells. However, monotherapy of patients with malignancy with IL-15 that has been initiated may not be optim...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3370156/ https://ncbi.nlm.nih.gov/pubmed/22593619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1102604 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|